18 April 2024 — Inviga Healthcare Fund (IHF), a Bengaluru-based healthcare-focused private equity fund, has successfully raised $20 million in its first close. The fund aims to support ventures in the healthcare, pharmaceutical, and life sciences sectors.
Dr B S Ajaikumar, Executive Chairman of HealthCare Global Enterprises, and Ajay Garg, Founder of Equirus Capital, founded IHF with a vision to improve healthcare accessibility and quality in India. Dr Ajaikumar emphasized the fund’s goal of supporting doctor/healthcare entrepreneurs to drive positive change in the industry.
IHF’s investment focus spans the entire healthcare value chain, from pharmaceuticals to life sciences. The fund seeks to empower innovative ventures that address critical healthcare challenges and contribute to societal well-being.
IHF’s maiden investment is in Mynvax, a biotech startup specializing in novel recombinant vaccines for human respiratory viral diseases, including influenza and COVID-19. Founded by experts from the Indian Institute of Science, Mynvax exemplifies IHF’s commitment to supporting cutting-edge solutions in healthcare.
Garg highlighted IHF’s potential to transform India’s healthcare landscape through strategic investments. The fund’s emphasis on doctor-driven initiatives and thematic investments positions it uniquely to overcome technical barriers and drive impactful change.
Conclusion:
Inviga Healthcare Fund’s successful fundraising and strategic investments in ventures like Mynvax demonstrate a strong commitment to driving healthcare innovation and improving healthcare outcomes in India.
Source: Link
